Search

23 Feb 2024: necrosis factor-alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). ... The department has an interest in innate immunity, B cell lineage and repertoire development; natural and vaccine induced immunity to

14 Aug 2023: Activation of the second gate input is the key to unlocking translation; specifically, translation can be induced when a second promoter (for example, P. ... coli-infected mice, potentiated killing of antibiotic-resistant bacteria and, importantly,

14 Aug 2023: Activation of the second gate input is the key to unlocking translation; specifically, translation can be induced when a second promoter (for example, P. ... coli-infected mice, potentiated killing of antibiotic-resistant bacteria and, importantly,

14 Aug 2023: DETAILS. Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. (Request Permission) Unless otherwise indicated, all materials in this PDF are copyrighted by the National

18 Sep 2023: Cambridge can seem like a scary place, where imposter syndrome can rear its ugly and unpleasant head.

23 Feb 2024: the process by which new variants likely arise, and also reporting the first data on Pfizer BioNTech vaccine-induced antibody responses against the B.1.1.7 ‘Kent UK’ variant. ... His research investigates the basis for pathological immune activation

23 Feb 2024: Primary Immune Disorders (PID) This study focuses on genetic causes of severe immune disorders, also known as Primary ImmunoDeficiencies with the largest category being CVID, but it may also include the ... Steroid Resistant Nephrotic Syndrome (SRNS)

23 Feb 2024: Cambridge Cardiovascular - Wellcome Sanger Institute https://www.cardiovascular.cam.ac.uk/institutions/dir-sanger en Jack Palmer https://www.cardiovascular.cam.ac.uk/staff/jack-palmer <div class="field field-name-body field-type-text-with-summary

23 Feb 2024: The team is also characterising the virology of key spike protein mutations in new variants and their impact on natural and vaccine induced immunity. ... Simian Immunodeficiency Virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by

23 Feb 2024: Large genome-wide association study identifies three novel risk variants for restless legs syndrome. ... Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature. 2020 Jul;583(7814):90-95.